First Header Logo Second Header Logo

Connection

Elisabeth Tallant to Angiotensin II

This is a "connection" page, showing publications Elisabeth Tallant has written about Angiotensin II.
Connection Strength

3.209
  1. McCollum LT, Gallagher PE, Tallant EA. Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides. 2012 Apr; 34(2):380-8.
    View in: PubMed
    Score: 0.370
  2. Diz DI, Arnold AC, Nautiyal M, Isa K, Shaltout HA, Tallant EA. Angiotensin peptides and central autonomic regulation. Curr Opin Pharmacol. 2011 Apr; 11(2):131-7.
    View in: PubMed
    Score: 0.347
  3. Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. . 2008 Nov; 295(5):C1169-74.
    View in: PubMed
    Score: 0.292
  4. Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. . 2006 Feb; 290(2):C420-6.
    View in: PubMed
    Score: 0.238
  5. Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension. 2003 Oct; 42(4):574-9.
    View in: PubMed
    Score: 0.207
  6. McCollum LT, Gallagher PE, Ann Tallant E. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. . 2012 Feb 01; 302(3):H801-10.
    View in: PubMed
    Score: 0.183
  7. Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 1999 Oct; 34(4 Pt 2):950-7.
    View in: PubMed
    Score: 0.157
  8. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 1999 Jan; 33(1 Pt 2):207-11.
    View in: PubMed
    Score: 0.150
  9. Tallant EA, Higson JT. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia. 1997 Apr; 19(4):333-42.
    View in: PubMed
    Score: 0.132
  10. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997 Jan; 29(1 Pt 2):388-93.
    View in: PubMed
    Score: 0.130
  11. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996 Jul; 28(1):104-8.
    View in: PubMed
    Score: 0.126
  12. Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. Am J Hypertens. 1995 Nov; 8(11):1105-11.
    View in: PubMed
    Score: 0.120
  13. Carver KA, Smith TL, Gallagher PE, Tallant EA. Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation. 2015 Jan; 22(1):19-27.
    View in: PubMed
    Score: 0.113
  14. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991 Nov; 18(5 Suppl):III126-33.
    View in: PubMed
    Score: 0.091
  15. Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts. . 2008 Dec; 295(6):H2373-9.
    View in: PubMed
    Score: 0.074
  16. Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB. Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. J Renin Angiotensin Aldosterone Syst. 2004 Dec; 5(4):176-82.
    View in: PubMed
    Score: 0.056
  17. Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004 May; 43(5):970-6.
    View in: PubMed
    Score: 0.054
  18. Clark MA, Diz DI, Tallant EA. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension. 2001 Apr; 37(4):1141-6.
    View in: PubMed
    Score: 0.044
  19. Brosnihan KB, Li P, Tallant EA, Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res. 1998; 31(3):227-34.
    View in: PubMed
    Score: 0.035
  20. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 1997 Sep; 30(3 Pt 2):535-41.
    View in: PubMed
    Score: 0.034
  21. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995 Jun; 25(6):1260-5.
    View in: PubMed
    Score: 0.029
  22. Freeman EJ, Tallant EA. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation. Biochem J. 1994 Dec 01; 304 ( Pt 2):543-8.
    View in: PubMed
    Score: 0.028
  23. Nautiyal M, Katakam PV, Busija DW, Gallagher PE, Tallant EA, Chappell MC, Diz DI. Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system. . 2012 Oct 15; 303(8):R799-806.
    View in: PubMed
    Score: 0.024
  24. Tallant EA, Jaiswal N, Diz DI, Ferrario CM. Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension. 1991 Jul; 18(1):32-9.
    View in: PubMed
    Score: 0.022
  25. Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension. 1991 Jun; 17(6 Pt 2):1135-43.
    View in: PubMed
    Score: 0.022
  26. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. Am J Hypertens. 1991 Mar; 4(3 Pt 1):228-33.
    View in: PubMed
    Score: 0.022
  27. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides. 1990 Mar-Apr; 11(2):375-80.
    View in: PubMed
    Score: 0.020
  28. Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM. Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther Adv Cardiovasc Dis. 2010 Feb; 4(1):17-25.
    View in: PubMed
    Score: 0.020
  29. Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. . 2006 Nov; 291(5):H2166-72.
    View in: PubMed
    Score: 0.016
  30. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005 May 24; 111(20):2605-10.
    View in: PubMed
    Score: 0.015
  31. Clark MA, Tallant EA, Diz DI. Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). J Cardiovasc Pharmacol. 2001 Apr; 37(4):437-48.
    View in: PubMed
    Score: 0.011
  32. Strawn WB, Gallagher PE, Tallant EA, Ganten D, Ferrario CM. Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats. J Cardiovasc Pharmacol. 1999 Mar; 33(3):341-51.
    View in: PubMed
    Score: 0.009
  33. Jaiswal N, Jaiswal RK, Tallant EA, Diz DI, Ferrario CM. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells. Hypertension. 1993 Jun; 21(6 Pt 2):900-5.
    View in: PubMed
    Score: 0.006
  34. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991 Jun; 17(6 Pt 2):1115-20.
    View in: PubMed
    Score: 0.006
  35. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991 May; 260(5 Pt 2):R1000-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.